Some doctors have used the types of cells to differentiate the types of mesothelioma. However, the type of cells associated with the tumor did not have any impact on the symptoms presented by the patient and only has a small impact on the prognosis of life. As a result, most of the doctors refer to cancer mesothelioma at the cellular level when they are deciding if the patient is eligible to start in any clinical trial or any innovative treatment.
Mesothelioma-type epithelial is the most common within this category and is responsible for between 50 and 70 percent of the tumors that affect the small cells, in the form of a tube. This type of cancer is that it usually responds best to the treatments applied and as a result gives patients a prognosis of life more extended.
The mesothelioma type, sarcomatoid is the least common and accounts for only 7 percent of the diagnoses. However, when these cells are affected, they are usually part of a tumor with pleural mesothelioma. The groups of fibers in the form of a spiral rarely respond to the applied treatments and the prognosis for affected patients is not very long.
When the cancer mesothelioma epithelial and sarcomatoid are involved in a tumor affected by the cancer mesothelioma, doctors refer to it as a type of mesothelioma biphasic. Just a quarter of patients have a mixture of this type of cells.